Controlled release properties and final macroporosity of a pectin microspheres-calcium phosphate composite bone cement

Acta Biomaterialia
S Girod FullanaF Rodriguez

Abstract

The use of calcium phosphate cements (CPC) is restricted by their lack of macroporosity and poor drug release properties. To overcome these two limitations, incorporating degradable polymer microparticles into CPC is an attractive option, as polymer microparticles could help to control drug release and induce macroporosity after degradation. Although few authors have yet tested synthetic polymers, the potentiality of polysaccharides' assuming this role has never been explored. Low-methoxy amidated pectins (LMAP) constitute valuable candidates because of their biocompatibility and ionic and pH sensitivity. In this study, the potentiality of a LMAP with a degree of esterification (DE) of 30 and a degree of amidation (DA) of 19 was explored. The aim of this study was to explore the influence of LMAP microspheres within the composite on the cement properties, drug release ability and final macroporosity after microspheres degradation. Three LMAP incorporation ratios, 2%, 4% and 6% w/w were tested, and ibuprofen was chosen as the model drug. In comparison with the CPC reference, the resulting composites presented reduced setting times and lowered the mechanical properties, which remained acceptable for an implantation in moderate-st...Continue Reading

References

Jun 24, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Sriamornsak
Mar 12, 2002·The Journal of Craniofacial Surgery·Cameron M L ClokieGeorge K B Sandor
May 10, 2002·Journal of Biomedical Materials Research·E M OomsJ A Jansen
Jun 1, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Carl G SimonFrancis W Wang
Apr 30, 2005·Biomaterials·Vassilis Karageorgiou, David Kaplan
Jun 24, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·P Q RuhéJ A Jansen
Jul 26, 2005·Journal of Biomedical Materials Research. Part a·P Quinten RuhéAntonios G Mikos
Dec 8, 2005·Biomaterials·Maria-Pau GinebraJosep A Planell
Feb 2, 2006·Biomaterials·Tadashi Kokubo, Hiroaki Takadama
Jun 23, 2006·International Journal of Pharmaceutics·O ChambinY Pourcelot
Feb 13, 2007·Biomacromolecules·Hanna E KokkonenJuha Tuukkanen
Aug 11, 2007·Journal of Biomedical Materials Research. Part a·Michael D Weir, Hockin H K Xu
Aug 19, 2007·Journal of Materials Science. Materials in Medicine·Zhengqi FeiHongxun Song
Nov 16, 2007·Journal of Biomedical Materials Research. Part a·Cyrill BussyMarie-Danielle Nagel
Jan 15, 2008·Journal of Biomedical Materials Research. Part a·W J E M HabrakenJ A Jansen
Jan 18, 2008·Journal of Biomedical Materials Research. Part a·Dennis P LinkJohn A Jansen
Aug 6, 2008·Biomacromolecules·H KokkonenJ Tuukkanen
Nov 6, 2008·Journal of Biomedical Materials Research. Part a·W J E M HabrakenJ A Jansen
Dec 5, 2008·Journal of Materials Science. Materials in Medicine·Meng LiKeming Chen

❮ Previous
Next ❯

Citations

Feb 21, 2013·Journal of Materials Science. Materials in Medicine·Tapan Kumar GiriDulal Krishna Tripathi
Aug 3, 2011·Tissue Engineering. Part B, Reviews·Huanan WangJohn A Jansen
Jun 1, 2011·Probiotics and Antimicrobial Proteins·Anton D van StadenLeon M T Dicks
Dec 3, 2015·International Journal of Biological Macromolecules·Takashi IsobeYoshifumi Murata
Feb 9, 2012·Advanced Drug Delivery Reviews·Maria-Pau GinebraEdgar B Montufar
Jul 21, 2011·International Journal of Pharmaceutics·Ahmed Al-KattanChristophe Drouet
Nov 27, 2015·International Journal of Biological Macromolecules·M Saquib HasnainTahseen Jahan Ara
Aug 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·E A BayerS R Little
Oct 20, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Gemma MestresCecilia Persson
May 18, 2011·Biotechnology Progress·Mariana B Oliveira, João F Mano
Jan 25, 2012·Journal of Applied Microbiology·A D van StadenL M T Dicks
Sep 27, 2014·Carbohydrate Polymers·Anja VeronovskiZoran Novak
Feb 18, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Dagnija LocaZilgma Irbe
Dec 30, 2014·International Journal of Pharmaceutics·T Marras-MarquezM D Veiga-Ochoa
Jan 1, 2013·Journal of Functional Biomaterials·Sergey V Dorozhkin
Nov 4, 2017·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Angel ManchónEnrique Lopez Cabarcos
May 14, 2019·Journal of Biomedical Materials Research. Part a·S M Hossein DabiriLaura Pastorino
Sep 2, 2021·Bioactive Materials·Marco FoscaVuk Uskoković

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.